Log in

Arix Bioscience Stock Price, News & Analysis (LON:ARIX)

GBX 119
+0.50 (+0.42 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
Now: GBX 119
50-Day Range
MA: GBX 114.12
52-Week Range
Now: GBX 119
Volume88,893 shs
Average Volume65,433 shs
Market Capitalization£161.31 million
P/E RatioN/A
Dividend YieldN/A
Arix Bioscience plc, formerly known as Perceptive Bioscience Investments Limited, is a venture capital firm specializing in seed, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, medical innovation comprising healthcare and life sciences. It seeks to invest globally. The firm employs an evergreen approach to funding. It primarily makes investments from its own balance sheet. The firm prefers to take board seat. The firm exit when the optimum value has been reached. Arix Bioscience plc is based in London, United Kingdom with an additional office in New York, New York.

Industry, Sector and Symbol

Industry Biotechnology



Sales & Book Value

Annual Sales£-21,632,000.00
Cash FlowGBX 45.25 per share
Book ValueGBX 171.10 per share



Market Cap£161.31 million
Next Earnings DateN/A
OptionableNot Optionable

Receive ARIX News and Ratings via Email

Sign-up to receive the latest news and ratings for ARIX and its competitors with MarketBeat's FREE daily newsletter.

Arix Bioscience (LON:ARIX) Frequently Asked Questions

What is Arix Bioscience's stock symbol?

Arix Bioscience trades on the London Stock Exchange (LON) under the ticker symbol "ARIX."

What price target have analysts set for ARIX?

2 Wall Street analysts have issued twelve-month price targets for Arix Bioscience's stock. Their forecasts range from GBX 270 to GBX 270. On average, they anticipate Arix Bioscience's share price to reach GBX 270 in the next year. This suggests a possible upside of 126.9% from the stock's current price. View Analyst Price Targets for Arix Bioscience.

What is the consensus analysts' recommendation for Arix Bioscience?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Arix Bioscience in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Arix Bioscience.

Has Arix Bioscience been receiving favorable news coverage?

Media headlines about ARIX stock have been trending very negative on Saturday, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Arix Bioscience earned a daily sentiment score of -3.8 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Arix Bioscience.

Who are some of Arix Bioscience's key competitors?

What other stocks do shareholders of Arix Bioscience own?

Who are Arix Bioscience's key executives?

Arix Bioscience's management team includes the folowing people:
  • Dr. Joseph Anderson, CEO & Co-Founder (Age 60)
  • Mr. James Hedley Rawlingson, Chief Financial Officer (Age 51)
  • Sir Christopher Thomas Evans, Consultant (Age 62)
  • Mr. Robert Lyne, COO, Gen. Counsel & Company Sec.
  • Ms. Charlotte Parry, Head of Investor Relations

How do I buy shares of Arix Bioscience?

Shares of ARIX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Arix Bioscience's stock price today?

One share of ARIX stock can currently be purchased for approximately GBX 119.

How big of a company is Arix Bioscience?

Arix Bioscience has a market capitalization of £161.31 million and generates £-21,632,000.00 in revenue each year. Arix Bioscience employs 14 workers across the globe.View Additional Information About Arix Bioscience.

What is Arix Bioscience's official website?

The official website for Arix Bioscience is http://arixbioscience.com/.

How can I contact Arix Bioscience?

Arix Bioscience's mailing address is 20 Berkeley Square, LONDON, W1J 6EQ, United Kingdom. The company can be reached via phone at +44-20-72901050.

MarketBeat Community Rating for Arix Bioscience (LON ARIX)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  67 (Vote Outperform)
Underperform Votes:  82 (Vote Underperform)
Total Votes:  149
MarketBeat's community ratings are surveys of what our community members think about Arix Bioscience and other stocks. Vote "Outperform" if you believe ARIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ARIX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/19/2019 by MarketBeat.com Staff

Featured Article: Stocks Increasing Dividends

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel